Another meta-analysis [62] evaluated XPG polymorphisms and found that rs1047768 polymorphism was linked to an increased risk of lung cancer, rs2227869 polymorphism was associated with a decreased risk of cancer in population-based studies, and rs751402 and rs873601 polymorphisms were connected to the risk of gastric cancer. Here, ERCC5 is linked to lung cancer.